A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System (CATALYSTEM)
Sponsor: Smith & Nephew, Inc.
This observational or N/A phase trial investigates Avascular Necrosis and Congenital Hip Dysplasia and is currently ongoing. Smith & Nephew, Inc. leads this study, which shows 9 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Dec 2025 — Mar 2026 [monthly]
Enrolling By Invitation
-
Nov 2025 — Dec 2025 [monthly]
Enrolling By Invitation
-
Sep 2025 — Nov 2025 [monthly]
Enrolling By Invitation
-
Jul 2025 — Sep 2025 [monthly]
Enrolling By Invitation
▶ Show 4 earlier versions
-
Jun 2025 — Jul 2025 [monthly]
Enrolling By Invitation
-
Apr 2025 — Jun 2025 [monthly]
Enrolling By Invitation
-
Nov 2024 — Apr 2025 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Sep 2024 — Nov 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Smith & Nephew, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .